South Korea
· Delayed Price · Currency is KRW Sam-A Pharm. Statistics
Total Valuation
Sam-A Pharm. has a market cap or net worth of KRW 106.87 billion. The enterprise value is 33.82 billion.
| Market Cap | 106.87B |
| Enterprise Value | 33.82B |
Important Dates
The next estimated earnings date is Thursday, August 14, 2025.
| Earnings Date | Aug 14, 2025 |
| Ex-Dividend Date | Dec 27, 2024 |
Share Statistics
Sam-A Pharm. has 6.10 million shares outstanding. The number of shares has increased by 0.02% in one year.
| Current Share Class | 6.10M |
| Shares Outstanding | 6.10M |
| Shares Change (YoY) | +0.02% |
| Shares Change (QoQ) | +0.04% |
| Owned by Insiders (%) | 68.45% |
| Owned by Institutions (%) | n/a |
| Float | 1.93M |
Valuation Ratios
The trailing PE ratio is 5.62.
| PE Ratio | 5.62 |
| Forward PE | n/a |
| PS Ratio | 1.19 |
| PB Ratio | 0.48 |
| P/TBV Ratio | 0.49 |
| P/FCF Ratio | 6.86 |
| P/OCF Ratio | 5.14 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 1.44, with an EV/FCF ratio of 2.17.
| EV / Earnings | 1.78 |
| EV / Sales | 0.38 |
| EV / EBITDA | 1.44 |
| EV / EBIT | 1.76 |
| EV / FCF | 2.17 |
Financial Position
The company has a current ratio of 4.46, with a Debt / Equity ratio of 0.05.
| Current Ratio | 4.46 |
| Quick Ratio | 3.86 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | 0.46 |
| Debt / FCF | 0.73 |
| Interest Coverage | 37.99 |
Financial Efficiency
Return on equity (ROE) is 8.90% and return on invested capital (ROIC) is 5.69%.
| Return on Equity (ROE) | 8.90% |
| Return on Assets (ROA) | 5.12% |
| Return on Invested Capital (ROIC) | 5.69% |
| Return on Capital Employed (ROCE) | 8.96% |
| Revenue Per Employee | 300.42M |
| Profits Per Employee | 63.33M |
| Employee Count | 300 |
| Asset Turnover | 0.36 |
| Inventory Turnover | 2.30 |
Taxes
In the past 12 months, Sam-A Pharm. has paid 6.24 billion in taxes.
| Income Tax | 6.24B |
| Effective Tax Rate | 24.73% |
Stock Price Statistics
The stock price has decreased by -9.07% in the last 52 weeks. The beta is 0.31, so Sam-A Pharm.'s price volatility has been lower than the market average.
| Beta (5Y) | 0.31 |
| 52-Week Price Change | -9.07% |
| 50-Day Moving Average | 16,861.60 |
| 200-Day Moving Average | 18,380.45 |
| Relative Strength Index (RSI) | 55.58 |
| Average Volume (20 Days) | 8,520 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Sam-A Pharm. had revenue of KRW 90.13 billion and earned 19.00 billion in profits. Earnings per share was 3,113.03.
| Revenue | 90.13B |
| Gross Profit | 56.54B |
| Operating Income | 20.45B |
| Pretax Income | 25.24B |
| Net Income | 19.00B |
| EBITDA | 24.71B |
| EBIT | 20.45B |
| Earnings Per Share (EPS) | 3,113.03 |
Balance Sheet
The company has 84.46 billion in cash and 11.40 billion in debt, giving a net cash position of 73.05 billion or 11,969.27 per share.
| Cash & Cash Equivalents | 84.46B |
| Total Debt | 11.40B |
| Net Cash | 73.05B |
| Net Cash Per Share | 11,969.27 |
| Equity (Book Value) | 221.41B |
| Book Value Per Share | 36,277.07 |
| Working Capital | 96.06B |
Cash Flow
In the last 12 months, operating cash flow was 20.79 billion and capital expenditures -5.22 billion, giving a free cash flow of 15.58 billion.
| Operating Cash Flow | 20.79B |
| Capital Expenditures | -5.22B |
| Free Cash Flow | 15.58B |
| FCF Per Share | 2,552.28 |
Margins
Gross margin is 62.73%, with operating and profit margins of 22.69% and 21.08%.
| Gross Margin | 62.73% |
| Operating Margin | 22.69% |
| Pretax Margin | 28.01% |
| Profit Margin | 21.08% |
| EBITDA Margin | 27.42% |
| EBIT Margin | 22.69% |
| FCF Margin | 17.28% |
Dividends & Yields
This stock pays an annual dividend of 800.00, which amounts to a dividend yield of 4.56%.
| Dividend Per Share | 800.00 |
| Dividend Yield | 4.56% |
| Dividend Growth (YoY) | 6.67% |
| Years of Dividend Growth | 3 |
| Payout Ratio | 24.09% |
| Buyback Yield | -0.02% |
| Shareholder Yield | 4.50% |
| Earnings Yield | 17.78% |
| FCF Yield | 14.58% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on December 29, 2008. It was a forward split with a ratio of 1.02005.
| Last Split Date | Dec 29, 2008 |
| Split Type | Forward |
| Split Ratio | 1.02005 |
Scores
Sam-A Pharm. has an Altman Z-Score of 4.28 and a Piotroski F-Score of 6.
| Altman Z-Score | 4.28 |
| Piotroski F-Score | 6 |